Skip to main content
Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer

Fig. 3

Higher IDO1 protein levels in tumor are associated with decreased B-cell infiltration in hormone receptor-positive breast cancer. Plots show levels of IDO1 protein according to CD3, CD8 and CD20 status in Yale hormone receptor-positive breast cancer cohort. TIL scores were stratified using median cut-point. The charts show mean ± standard error of the mean. Numbers under each category indicate the amount of cases in each group. AU: arbitrary unit of fluorescence. QIF: quantitative immunofluorescence

Back to article page